Author Archives: Natalie Themm
Recursion loops in Roche, Genentech for multibillion-dollar AI drug discovery deal
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.
ARUP Laboratories Earns Fourth Consecutive Utah Business Best Companies To Work For Award
For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Renalytix reported financial results for the quarter ended September 30, 2021.
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology
The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test
Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).
Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India
Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.
HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler
Collaboration Expands Clinical Sites for Trial
NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
IONIQ Sciences proudly announces that Mrs. Jan Poulsen is a Lung Cancer Hero
IONIQ Sciences Proudly Announces that Mrs. Jan Poulsen is a Lung Cancer Hero
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
None of the mutations in the Omicron variant interfere with any of the Company’s COVID-19 PCR diagnostic assays
